Stifel Downgrades Glaukos Corporation (GKOS) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Glaukos Corporation (GKOS) Reports 2-Yr U.S. IDE Pivotal Trial Results for iStent Inject Show Significant Reductions in Unmedicated IOP in Glaucoma Subjects Undergoing Cataract Surgery
April 16, 2018 5:46 AM EDTGlaukos Corporation (NYSE: GKOS) today announced that two-year U.S. Investigational Device Exemption (IDE) pivotal trial data showed that its iStent inject® Trabecular Micro-Bypass System achieved a statistically significant reduction in unmedicated diurnal intraocular pressure (IOP) in patients undergoing cataract surgery.
Results of the iStent inject prospective, randomized, multicenter clinical trial, which included 41 investigational sites and 505 open-angle glaucoma (OAG) subjects, were presented today at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting by Thomas W. Samuelson, MD, an ophthalmic surgeon at Minnesota Eye Consultants. In the study,... More
Glaukos Corporation (GKOS) Reports Filing of Patent Infringement Lawsuit Against Ivantis Inc.
April 16, 2018 5:43 AM EDTGlaukos Corporation (NYSE: GKOS) today announced that it has filed a patent infringement lawsuit against Ivantis, Inc. in the U.S. District Court for the Central District of California, Southern Division. The lawsuit alleges that Ivantis Hydrus Microstent device infringes Glaukos patents relating to certain of... More
